Report: J&J's Lancaster, Pa., plant under fire

NEW YORK A third Johnson & Johnson manufacturing facility has come under Food and Drug Administration scrutiny following an inspection, according to published reports.

J&J confirmed it had received a Form 483 from the FDA regarding its Lancaster, Pa., plant, which is a joint venture between J&J and Merck Consumer Pharmaceuticals that manufacturers the heartburn remedy Pepcid.

J&J also revealed the company had received a grand jury subpoena from the U.S. Attorney's Office in Philadelphia during its conference call on Tuesday, though declined to provide more information on that matter.

Login or Register to post a comment.